pharma · Amyotrophic Lateral Sclerosis · Acute Myeloid Leukemia
AB Science
AB Science clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- PARIS, FR
- Employees
- 20
- Programs
- 6
- Drugs
- 11
- Patents
- 25
AB Science projects
6 ClinicalTrials.gov programs sponsored by AB Science.
AB Science has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AB15003
AB Science
Mastocytosis
1 trial -
AB19001
AB Science
Amyotrophic Lateral Sclerosis
1 trial -
AB20009
AB Science
Multiple Sclerosis
1 trial -
AB23005
AB Science
Amyotrophic Lateral Sclerosis
1 trial -
AB18001
AB Science
Acute Myeloid Leukemia
1 trial -
AB20006
AB Science
Mast cell activation syndrome
1 trial
Frequently asked questions
How many clinical projects does AB Science have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.